On November 5, the health of the United States continued the weak trend of the previous trading day and continued to drop. By the end of the day, the company’s share price fell 9.96% to close at 12.38 yuan, with a turnover of 1.795 billion yuan and a turnover rate of 3.90%. Since October 30, meinian health has fallen for five consecutive trading days. Its stock price has declined by 28.97% from 17.43 yuan on October 30, and the market value has evaporated by nearly 20 billion yuan. < p > < p > on the evening of April 4, meinian Health announced that it received a notice on changes in its holding of meinian health shares issued by Alibaba (China) Network Technology Co., Ltd. (hereinafter referred to as “Alibaba network”) which is more than 5% of the company’s shareholders. As of November 3, 2020, Alibaba network has accumulated 53.9926 million shares of the company through the block trading system of Shenzhen Stock Exchange, accounting for 1.3794% of the total share capital of the company. After the reduction, the shares held by Alibaba network and its people acting in concert decreased from 564 million shares to 510 million shares. < p > < p > was reduced by Ali, which may be related to the poor health performance of the United States. According to the third quarter report of 2020 recently released by the company, the first three quarters of this year achieved revenue of 4.42 billion yuan, a year-on-year decrease of 29.6%; the net profit attributable to the parent was – 520 million yuan, a year-on-year decrease of 232.2%. From the single quarter data, the company achieved revenue of 2.6 billion yuan in the third quarter, a year-on-year decrease of 1.2%, and a month on month increase of 103.6%; the net profit attributable to the parent company in the single quarter was 270 million yuan, a year-on-year decrease of 29.2%, and a quarter on month increase of 244.3%. In addition, during the reporting period, the company’s gross profit margin was 28.9%, a year-on-year decrease of 12.56 percentage points. However, in the third quarter report, the company expects to turn losses into profits in 2020, with a net profit of 10 million yuan to 30 million yuan. The company said that with the weakening of the impact of the epidemic, various policy support and the public’s demand for their own health care is gradually releasing, the company’s business performance has continued to rebound. At the same time, the company is actively promoting the transfer of some shares of the holding subsidiary Meiyin Health Technology (Beijing) Co., Ltd. If the transaction is successful, the investment income generated by equity transfer belongs to non recurring profit and loss, which is expected to have an important impact on the company’s net profit. < / P > < p > Disclaimer: the purpose of this article reprinted by china.com finance and economics is to convey more information and does not represent the views and positions of the website. The content of this paper is for reference only and does not constitute investment advice. Investors operate accordingly and bear their own risks. < p > < p > Chinanet is a national key news website under the leadership of the Information Office of the State Council and managed by China foreign language publishing and Distribution Bureau. Through 11 versions in 10 languages, the website releases information 24 hours a day, which is an important window for China to carry out international communication and information exchange.